other
confidence high
sentiment neutral
materiality 0.40
Lifecore Biomedical approves FY2025 Annual Incentive Plan with EBITDA-based bonuses
LIFECORE BIOMEDICAL, INC. DE
- CEO Paul Josephs target bonus 100% of base salary; CFO John D. Morberg 60%.
- Plan weighted 80% on Adjusted EBITDA and 20% on four business objectives.
- Maximum payout capped at 200% of target; minimum EBITDA threshold required.
- Clawback provision under Compensation Recoupment Policy applies to all payments.